BIG
CORT icon

Brookwood Investment Group’s Corcept Therapeutics CORT Stock Holding History

Brookwood Investment Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,982
Closed -$663K – 522
2025
Q3 		$663K Sell
7,982
-7,384
-48% -$534K 0.09% 215
2025
Q2 		$1.13M Buy
15,366
+5,435
+55% +$394K 0.18% 107
2025
Q1 		$1.13M Buy
+9,931
New +$604K 0.19% 101

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brookwood Investment Group's CORT Position: Q4 2025 in Review

Brookwood Investment Group sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 7,982 shares — an estimated $663K sold.

Brookwood Investment Group first reported a position in CORT in Q1 2025 and held it in 3 quarters. The position peaked at $1.13M in Q1 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Brookwood Investment Group reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Brookwood Investment Group sold 7,982 Corcept Therapeutics shares in Q4 2025, an estimated $663K.
  • Brookwood Investment Group first reported a position in Corcept Therapeutics in Q1 2025 and held it in 3 quarters.
  • Brookwood Investment Group's Corcept Therapeutics position peaked at $1.13M in Q1 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Brookwood Investment Group's 13F filing for Q4 2025, filed 22 Jan 2026.